‘Depression and Anxiety in Parkinson’s Disease': Michael J Fox Foundation Third Thursday webinar

Resources & Tools

Author: Parkinson's Life editorsPublished: 15 February 2018

Prep: Cook: Serves:

This month’s free webinar from the Michael J Fox Foundation will discuss mental health problems surrounding Parkinson’s disease

On Thursday 15 February the Michael J Fox Foundation – as part of their Third Thursday webinar series – is replaying a podcast entitled ‘Depression and Anxiety in Parkinson’s disease’.

The hour-long webinar is hosted by broadcast journalist and person with Parkinson’s Dave Iverson, who is joined by a panel of experts.

It is not uncommon for people to feel anxious or depressed after receiving a Parkinson’s diagnosis. The webinar discusses the mental health issues surrounding the condition and offers advice on how to manage symptoms.

It’s free to join the webinar, just register here up to 15 minutes before its start time at 12:00 EST. If you can’t make the broadcast, you can catch up from the recordings library here.

For comprehensive information on non-motor symptoms please visit the European Parkinson’s Disease Association (EPDA) website.

Whatever happened to stem cells? Tune in to this free MJFF live webinar

Last Month

Next Month

Go Back

Share this story

Comments

Perspectives

Who said what: QoTW 04.06.15

Our favourite quotes of the week from around the web

A chance to tell your story to the world

Submissions for the competition are open

Rich chocolate fondue with strawberries and pineapple

A quick, easy to digest dessert recipe

World War II weapon antidote could treat Parkinson’s

Researchers at Purdue University, US, are studying a World War II chemical weapon antidote that they believe could be used to treat Parkinson’s. It is believed the antidote, called dimercaprol, may be able to remove acrolein – a toxin that poisons neurons and can lead to the development of Parkinson’s disease. In addition to this, researchers believe dimercaprol can increase the survival rate of brain cells, improve mobility and reduce symptoms of pain. Riyi Shi, professor of neuroscience and biomedical engineering at Purdue University, said: “Our studies show that by removing the toxin (acrolein) from the brain, we are not just reducing the symptoms of Parkinson’s disease but also significantly reversing the damage of Parkinson’s disease. This could actually provide a new treatment for Parkinson’s patients.”

Repurposed cancer drug shows promise for Parkinson’s

Researchers at the Oxford Parkinson’s Disease Centre, UK, have repurposed an experimental cancer drug – called tasquinimod – as a potential treatment for Parkinson’s. The study – funded by Parkinson’s UK and published in science journal ‘Cell Stem Cell’ – has been tested on a total of 10 patients so far. As part of the research, the study grew brain cells from donated skin cell samples of people living with a rare genetic form of Parkinson’s – this process was then repeated on people with a common non-genetic form of the condition. Researchers found that tasquinimod can block HDAC4, a protein that causes Parkinson’s genes to become inactive. Professor Richard Wade-Martins, co-lead author of the study, said: “We think that switching off these genes in brain cells may play a vital role in the cell damage and death that occurs in Parkinson’s.”

Research survey assesses impact of holidays on Parkinson’s symptoms

The Radboud University Medical Center, Netherlands, is seeking participants for an online survey assessing the effects of a holiday on Parkinson’s. The study will assess whether a vacation can have physical and mental benefits for people living with the condition. It will also look at which specific factors, such as temperature and physical activity, can alleviate or increase symptoms. The Michael J Fox Foundation has approved the study’s protocol. Participants can sign up to complete the 20-minute survey online. The survey is open to anyone over 18 who has Parkinson’s and has been on vacation once or more between 1 June 2016 and 30 September 2018. Marjan Faber, the study’s daily supervisor, said: “If the study is able to identify decisive factors, those can act as a starting point for novel approaches in care for people with Parkinson’s disease.” To apply please visit research platform ParkinsonNEXT.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
Captcha
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

‘Depression and Anxiety in Parkinson’s Disease': Michael J Fox Foundation Third Thursday webinar

Resources & Tools

Author: Parkinson's Life editorsPublished: 15 February 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Perspectives

Who said what: QoTW 04.06.15

Global update

A chance to tell your story to the world

Recipes & Nutrition

Rich chocolate fondue with strawberries and pineapple

World War II weapon antidote could treat Parkinson’s

Repurposed cancer drug shows promise for Parkinson’s

Research survey assesses impact of holidays on Parkinson’s symptoms

{title}

Subscribe

‘Depression and Anxiety in Parkinson’s Disease': Michael J Fox Foundation Third Thursday webinar

Resources & Tools

Author: Parkinson's Life editorsPublished: 15 February 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Perspectives

Who said what: QoTW 04.06.15

Global update

A chance to tell your story to the world

Recipes & Nutrition

Rich chocolate fondue with strawberries and pineapple

World War II weapon antidote could treat Parkinson’s

Repurposed cancer drug shows promise for Parkinson’s

Research survey assesses impact of holidays on Parkinson’s symptoms

{title}

Subscribe

Sign in